For patients with viral hepatitis B, if the blood sampling for triple system suggests that the patient is positive for triple III positive. However, the blood test for liver function suggests that the patient’s liver function is normal, i.e., there is no elevation of ghrelin and ghrelin transaminases. If the patient’s further blood test for hepatitis B DNA suggests that the virus has replication, in this case, it is recommended that the patient continue to be observed, and the patient’s blood test for liver function will be conducted after one month to see whether the patient has elevated ghrelin or ghrelin, if the patient has elevated ghrelin or ghrelin in the later stage, it is considered to be in the window period of viral replication. Generally, antiviral treatment is more effective, you can actively consider interferon injection for antiviral treatment, or you can actively consider oral antiviral treatment with some antiviral drugs, such as lamivudine, entecavir, and other drugs orally, or interferon injections for about half a year to one year. After active antiviral treatment, the patient’s viral replication will tend to stabilize and the patient’s general condition will improve. However, if there is no elevation of ghrelin or ghrelin during the viral replication period, it is recommended that the patient should continue to be observed and not be treated with antiviral therapy for the time being, because oral or injectable antiviral drugs at this time are often ineffective in treating the disease.